These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25502526)

  • 1. Identification and susceptibility of Aspergillus section nigri in china: prevalence of species and paradoxical growth in response to echinocandins.
    Li Y; Wan Z; Liu W; Li R
    J Clin Microbiol; 2015 Feb; 53(2):702-5. PubMed ID: 25502526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex.
    Badali H; Fakhim H; Zarei F; Nabili M; Vaezi A; Poorzad N; Dolatabadi S; Mirhendi H
    Mycopathologia; 2016 Apr; 181(3-4):235-40. PubMed ID: 26615417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of disk diffusion method compared to broth microdilution for antifungal susceptibility testing of 3 echinocandins against Aspergillus spp.
    Martos AI; Martín-Mazuelos E; Romero A; Serrano C; González T; Almeida C; Puche B; Cantón E; Pemán J; Espinel-Ingroff A
    Diagn Microbiol Infect Dis; 2012 May; 73(1):53-6. PubMed ID: 22480568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Identification and In Vitro Antifungal Susceptibility of Aspergillus Isolates Recovered from Otomycosis Patients in Western China.
    Zhang L; Wang X; Houbraken J; Mei H; Liao W; Hasimu H; Liu W; Deng S
    Mycopathologia; 2020 Jun; 185(3):527-535. PubMed ID: 32346838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of clinical isolates of Aspergillus spp. to anidulafungin, caspofungin, and micafungin: a head-to-head comparison using the CLSI M38-A2 broth microdilution method.
    Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ
    J Clin Microbiol; 2009 Oct; 47(10):3323-5. PubMed ID: 19710267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro echinocandin susceptibility of Aspergillus isolates from patients enrolled in the Transplant-Associated Infection Surveillance Network.
    Lockhart SR; Zimbeck AJ; Baddley JW; Marr KA; Andes DR; Walsh TJ; Kauffman CA; Kontoyiannis DP; Ito JI; Pappas PG; Chiller T
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3944-6. PubMed ID: 21670187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-Kill Kinetics and In Vitro Antifungal Susceptibility of Non-fumigatus Aspergillus Species Isolated from Patients with Ocular Mycoses.
    Öz Y; Özdemir HG; Gökbolat E; Kiraz N; Ilkit M; Seyedmousavi S
    Mycopathologia; 2016 Apr; 181(3-4):225-33. PubMed ID: 26612621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Sensitivity and Resistance Mechanism in Aspergillus Section
    Hashimoto A; Hagiwara D; Watanabe A; Yahiro M; Yikelamu A; Yaguchi T; Kamei K
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607016
    [No Abstract]   [Full Text] [Related]  

  • 9. Antifungal activity of micafungin against Candida and Aspergillus spp. isolated from pediatric patients in Japan.
    Ikeda F; Saika T; Sato Y; Suzuki M; Hasegawa M; Mikawa T; Kobayashi I; Tsuji A
    Med Mycol; 2009 Mar; 47(2):145-8. PubMed ID: 18668422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective survey of Aspergillus species isolated from clinical specimens and their antifungal susceptibility: A five-year single-center study in Japan.
    Toyotome T; Saito S; Koshizaki Y; Komatsu R; Matsuzawa T; Yaguchi T
    J Infect Chemother; 2020 Feb; 26(2):321-323. PubMed ID: 31564504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Etest method for susceptibility testing of Aspergillus spp. and Fusarium spp. to three echinocandins.
    Martos AI; Romero A; González MT; González A; Serrano C; Castro C; Pemán J; Cantón E; Martín-Mazuelos E
    Med Mycol; 2010 Sep; 48(6):858-61. PubMed ID: 20144131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species Distribution and In Vitro Azole Susceptibility of Aspergillus Section Nigri Isolates from Clinical and Environmental Settings.
    Iatta R; Nuccio F; Immediato D; Mosca A; De Carlo C; Miragliotta G; Parisi A; Crescenzo G; Otranto D; Cafarchia C
    J Clin Microbiol; 2016 Sep; 54(9):2365-72. PubMed ID: 27413191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wild-type minimum effective concentration distributions and epidemiologic cutoff values for caspofungin and Aspergillus spp. as determined by Clinical and Laboratory Standards Institute broth microdilution methods.
    Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ
    Diagn Microbiol Infect Dis; 2010 May; 67(1):56-60. PubMed ID: 20207095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Albumin Enhances Caspofungin Activity against Aspergillus Species by Facilitating Drug Delivery to Germinating Hyphae.
    Ioannou P; Andrianaki A; Akoumianaki T; Kyrmizi I; Albert N; Perlin D; Samonis G; Kontoyiannis DP; Chamilos G
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1226-33. PubMed ID: 26643329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic re-identification and antifungal susceptibility testing of Aspergillus section Nigri strains of the BCCM/IHEM collection.
    Hendrickx M; Beguin H; Detandt M
    Mycoses; 2012 Mar; 55(2):148-55. PubMed ID: 21929560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of serum on in vitro susceptibility testing of echinocandins for Candida parapsilosis and Candida guilliermondii.
    Saribas Z; Yurdakul P; Cetin-Hazirolan G; Arikan-Akdagli S
    Mycoses; 2012 Mar; 55(2):156-60. PubMed ID: 21668525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A colorimetric and spectrophotometric method for in vitro susceptibility testing of Aspergillus species against caspofungin.
    Te Dorsthorst DT; Zwaaftink RB; Rijs AJ; Meletiadis J; Verweij PE
    Med Mycol; 2007 Jun; 45(4):351-5. PubMed ID: 17510858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective survey of Aspergillus spp. in respiratory tract samples: Species identification and susceptibility patterns.
    Castro C; Galán-Sanchez F; Linares MJ; Tejero R; Ruiz M; Serrano ML; Rodríguez-Iglesias M; Martín-Mazuelos E;
    Med Mycol; 2019 Jun; 57(4):412-420. PubMed ID: 30289467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Species identification and in vitro antifungal susceptibility testing of Aspergillus section Nigri strains isolated from otomycosis patients.
    Kamali Sarwestani Z; Hashemi SJ; Rezaie S; Gerami Shoar M; Mahmoudi S; Elahi M; Bahardoost M; Tajdini A; Abutalebian S; Daie Ghazvini R
    J Mycol Med; 2018 Jun; 28(2):279-284. PubMed ID: 29540288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species identification, antifungal susceptibility, and clinical feature association of Aspergillus section Nigri isolates from the lower respiratory tract.
    Takeda K; Suzuki J; Watanabe A; Matsuki M; Higa K; Inoue E; Akashi S; Shimada M; Kawashima M; Ohshima N; Fukami T; Masuda K; Yamane A; Tamura A; Nagai H; Matsui H; Tohma S; Kamei K
    Med Mycol; 2020 Apr; 58(3):310-314. PubMed ID: 31240316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.